Skip to content
10-Q

Quarterly Report

Luckwel Pharmaceuticals Inc.

0001493152-20-002208

← back to feed
Filed
Feb 13, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Feb 13, 2020 143.38M sh
Cash And Equivalents Q3 2020 · Dec 31, 2019 $33.92K
Cash And Equivalents Q3 2020 · Mar 31, 2019 $25.75K
Total Liabilities Q3 2020 · Dec 31, 2019 $1.22M
Total Liabilities Q3 2020 · Mar 31, 2019 $819.09K
Total Assets Q3 2020 · Dec 31, 2019 $47.05K
Total Assets Q3 2020 · Mar 31, 2019 $27.27K
Operating Cash Flow Q3 2020 · Dec 31, 2018 −$340.47K
Stockholders Equity Q3 2020 · Dec 31, 2018 −$811.56K
Stockholders Equity Q3 2020 · Sep 30, 2018 −$548.75K
Stockholders Equity Q3 2020 · Mar 31, 2018 −$129.3K
Sga Expense Q3 2020 · Dec 31, 2018 $262.81K
Sga Expense Q3 2020 · Dec 31, 2018 $642.27K
Net Income Q3 2020 · Dec 31, 2018 −$262.81K
Net Income Q3 2020 · Dec 31, 2018 −$642.26K